Ahmedabad-based Lincoln Pharmaceuticals Ltd., a pharmaceutical company with a legacy dating back to 1979, is strengthening its consumer healthcare portfolio with the addition of Namcold Oxy to its established Namcold brand. Positioned as the brand’s hero product, the nasal spray is built around a simple consumer promise – “Khulke Saans Lo” – and is designed to provide quick relief from a blocked nose, with the product acting in as little as 25 seconds.
Nasal congestion can turn an otherwise manageable cold into a persistent discomfort, affecting sleep, work, travel and everyday activities. With Namcold Oxy, the brand aims to offer consumers a convenient option for quick relief from a blocked nose. The nasal spray is positioned to act in as little as 25 seconds, making speed one of the key differentiators in its consumer proposition.
The launch and digital positioning of Namcold mark an important new chapter for the brand as it begins building a stronger presence among Indian consumers. While the product is relevant to people across age groups who experience nasal congestion, Namcold intends to particularly strengthen its reach across Tier 2 and Tier 3 cities, where consumer healthcare brands continue to see significant opportunities for growth and visibility.
The brand’s approach is centred on making nasal relief more accessible and easy to understand for everyday consumers. “Khulke Saans Lo” is therefore more than a campaign name for Namcold; it represents the core communication around the product – helping consumers get back to their daily routines without the prolonged discomfort of a blocked nose.
Behind Namcold is Lincoln Pharmaceuticals Ltd., an established Indian pharmaceutical company that has been operating since 1979. The company’s decades-long presence in the pharmaceutical sector provides the brand with an established foundation as it enters a more consumer-facing phase of communication. For Namcold, this association is expected to play an important role in building familiarity and trust as the brand establishes its identity in the digital space.
The nasal spray category in India features several well-known players across both domestic and global markets, making it a competitive space for brands seeking to build strong consumer recall. Against this backdrop, Namcold has set an ambitious target to emerge as the second market leader in the nasal spray category within the next three years. The brand’s strategy will focus on strengthening awareness around Namcold Oxy, building consumer familiarity and expanding its presence across markets, particularly in Tier 2 and Tier 3 cities.
As competition within the consumer healthcare market continues to evolve, brands are increasingly required to combine product efficacy with clear, relatable communication. Namcold’s strategy brings these two elements together by placing Namcold Oxy at the centre of its brand story and building its messaging around a benefit consumers can immediately understand.
With the backing of Lincoln Pharmaceuticals’ long-standing pharmaceutical experience and an ambitious vision for the future, Namcold is now looking to carve out its own space in India’s nasal relief market. Through Namcold Oxy and its “Khulke Saans Lo” proposition, the brand is setting its sights on becoming a familiar choice for consumers seeking quick relief from a blocked nose – and taking its first steps towards its larger ambition of becoming a leading player in the category.
